{"id":"W2990393697","doi":"10.1016/j.annder.2019.09.580","title":"Le certolizumab pegol dans le traitement du psoriasis en plaques : résultats d’efficacité sur 2 ans provenant de deux essais de phase 3 (CIMPASI-1 et CIMPASI-2)","year":2019,"lang":"fr","type":"article","venue":"Annales de Dermatologie et de Vénéréologie","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Certolizumab pegol; Medicine; Gynecology; Tumor necrosis factor alpha; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002049839,0.0007444127,0.001635017,0.0002667751,0.0003475586,0.0008235344,0.0003494724,0.001181739,0.001491299],"category_scores_gemma":[0.001053559,0.0003168873,0.001869048,0.0002225515,0.00051113,0.000753224,0.000286628,0.002430499,0.0004423214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004222148,"about_ca_system_score_gemma":0.00038266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009101194,"about_ca_topic_score_gemma":0.001063974,"domain_scores_codex":[0.9993706,0.0002303273,0.00005374422,0.00009262025,0.0001156887,0.0001370482],"domain_scores_gemma":[0.9994153,0.0002363402,0.00007748066,0.00007012275,0.00006900645,0.0001318344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1687988,0.03374408,0.01213359,0.00114771,0.003066705,0.003033228,0.001151538,0.007589204,0.258102,0.0005296065,0.004423151,0.5062803],"study_design_scores_gemma":[0.08232187,0.651812,0.09212022,0.0003479821,0.004440522,0.005618241,0.0004474963,0.005635709,0.1204957,0.0007863924,0.03576258,0.0002112676],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791504,0.01721555,0.0009748963,0.0005545584,0.0001484397,0.000217384,0.0002843511,0.00004889944,0.001405439],"genre_scores_gemma":[0.9854451,0.008563756,0.001586244,0.0007634594,0.0001864063,0.0001676886,0.001196182,0.00003567377,0.002055523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002049839,"threshold_uncertainty_score":0.01084071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02412976649007731,"score_gpt":0.290097446640366,"score_spread":0.2659676801502887,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}